GRI BIO, INC. (GRI) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current |
| Current obligations | 1.10M USD | Liabilities, Current |
| Cash and equivalents | 10.95M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Debt Securities, Available-for-sale, Current |
| Customer receivables | (m) | |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $1.10M | $10.95M | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $794.00K | $11.05M | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $2.64M | $8.23M | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $2.76M | $4.05M | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $2.31M | $5.12M | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $2.78M | $3.28M | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $1.64M | $5.03M | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $1.72M | $4.75M | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $2.22M | $6.35M | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $1.68M | $4.09M | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $2.70M | $1.81M | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $2.18M | $3.49M | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $1.60M | $4.80M | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | $1.67M | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $1.81M | $3.78M | $0.00 | (m) | (m) | (m) |
| 2022-09-30 | (m) | $2.11M | $4.73M | $419.00K | (m) | (m) | (m) |
| 2022-06-30 | (m) | $4.32M | $5.22M | $1.75M | (m) | (m) | (m) |
| 2022-03-31 | (m) | $2.54M | $2.54M | $2.63M | (m) | (m) | (m) |
| 2021-12-31 | (m) | $2.44M | $3.70M | $3.81M | (m) | (m) | (m) |
| 2021-09-30 | (m) | $1.31M | $5.88M | $3.25M | (m) | (m) | (m) |
| 2021-06-30 | (m) | $1.67M | $10.46M | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $2.43M | $12.98M | (m) | (m) | (m) | (m) |
| 2021-01-11 | (m) | (m) | $13.00M | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $2.23M | $109.00K | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.